Organic Letters
University, Guangzhou, Guangdong 511436, China;
Letter
Sundararaju, B. Catal. Sci. Technol. 2018, 8, 5963. (j) Tang, J.; Chen,
H.; He, Y.; Sheng, W.; Bai, Q.; Wang, H. Nat. Commun. 2018, 9,
3383. (k) Dong, Y.; Chen, J.; Xu, H. Chem. Commun. 2019, 55, 2027.
(4) For recently selected reviews since 2018, see: (a) Shao, Q.; Wu,
K.; Zhuang, Z.; Qian, S.; Yu, J.-Q. Acc. Chem. Res. 2020, 53, 833.
(b) Jiao, K.-J.; Xing, Y.-K.; Yang, Q.-L.; Qiu, H.; Mei, T.-S. Acc. Chem.
Res. 2020, 53, 300. (c) Rej, S.; Chatani, N. Angew. Chem., Int. Ed.
Authors
Liping Li − Guangzhou Municipal and Guangdong Provincial
Key Laboratory of Protein Modification and Degradation &
Molecular Target and Clinical Pharmacology, State Key
Laboratory of Respiratory Disease, School of Pharmaceutical
Sciences & the Fifth Affiliated Hospital, Guangzhou Medical
University, Guangzhou, Guangdong 511436, China
Hui Gao − Guangzhou Municipal and Guangdong Provincial
Key Laboratory of Protein Modification and Degradation &
Molecular Target and Clinical Pharmacology, State Key
Laboratory of Respiratory Disease, School of Pharmaceutical
Sciences & the Fifth Affiliated Hospital, Guangzhou Medical
University, Guangzhou, Guangdong 511436, China;
2019, 58, 8304. (d) Gandeepan, P.; Muller, T.; Zell, D.; Cera, G.;
̈
Warratz, S.; Ackermann, L. Chem. Rev. 2019, 119, 2192. (e) Diesel, J.;
Cramer, N. ACS Catal. 2019, 9, 9164. (f) Evano, G.; Theunissen, C.
Angew. Chem., Int. Ed. 2019, 58, 7202. (g) Sauermann, N.; Meyer, T.
H.; Qiu, Y.; Ackermann, L. ACS Catal. 2018, 8, 7086. (h) Tang, X.;
Wu, W.; Zeng, W.; Jiang, H. Acc. Chem. Res. 2018, 51, 1092.
(i) Karimov, R. R.; Hartwig, J. F. Angew. Chem., Int. Ed. 2018, 57,
4234. (j) Saint-Denis, T. G.; Zhu, R.-Y.; Chen, G.; Wu, Q.-F.; Yu, J.-
Q. Science 2018, 359, eaao4798. (k) Gandeepan, P.; Ackermann, L.
Chem. 2018, 4, 199. (l) Chu, J. C. K.; Rovis, T. Angew. Chem., Int. Ed.
2018, 57, 62.
(5) (a) Shin, K.; Kim, H.; Chang, S. Acc. Chem. Res. 2015, 48, 1040.
(b) Gensch, T.; Hopkinson, M. N.; Glorius, F.; Wencel-Delord, J.
Chem. Soc. Rev. 2016, 45, 2900. (c) Wei, Y.; Hu, P.; Zhang, M.; Su, W.
Chem. Rev. 2017, 117, 8864. (d) Dong, Z.; Ren, Z.; Thompson, S. J.;
Xu, Y.; Dong, G. Chem. Rev. 2017, 117, 9333. (e) Park, Y.; Kim, Y.;
Chang, S. Chem. Rev. 2017, 117, 9247. (f) Yang, Y.; Lan, J.; You, J.
Chem. Rev. 2017, 117, 8787. (g) Song, G.; Wang, F.; Li, X. Chem. Soc.
Rev. 2012, 41, 3651. (h) Colby, D. A.; Tsai, A. S.; Bergman, R. G.;
Ellman, J. A. Acc. Chem. Res. 2012, 45, 814. (i) Song, G.; Li, X. Acc.
Chem. Res. 2015, 48, 1007. (j) Qi, X.; Li, Y.; Bai, R.; Lan, Y. Acc.
Chem. Res. 2017, 50, 2799. (k) Ackermann, L. Chem. Rev. 2011, 111,
1315.
(6) For recent selected examples, see: (a) Knecht, T.; Pinkert, T.;
Dalton, T.; Lerchen, A.; Glorius, F. ACS Catal. 2019, 9, 1253. (b) Lei,
H.; Rovis, T. J. Am. Chem. Soc. 2019, 141, 2268. (c) Pinkert, T.;
Wegner, T.; Mondal, S.; Glorius, F. Angew. Chem., Int. Ed. 2019, 58,
15041. (d) Burman, J. S.; Harris, R. J.; Farr, C. M. B.; Bacsa, J.;
Blakey, S. B. ACS Catal. 2019, 9, 5474. (e) Knecht, T.; Mondal, S.;
Ye, J.-H.; Das, M.; Glorius, F. Angew. Chem., Int. Ed. 2019, 58, 7117.
(f) Phipps, E. J. T.; Rovis, T. J. Am. Chem. Soc. 2019, 141, 6807.
(7) For examples of sulfonamide-directed intermolecular alkenyl C−
H functionalization, see: (a) Ferguson, J.; Zeng, F.; Alwis, N.; Alper,
H. Org. Lett. 2013, 15, 1998. (b) Li, D.; Zeng, F. Org. Lett. 2017, 19,
6498. (c) Wu, L.; Meng, Y.; Ferguson, J.; Wang, L.; Zeng, F. J. Org.
Chem. 2017, 82, 4121. (d) Yu, R.; Li, D.; Zeng, F. J. Org. Chem. 2018,
83, 323. (e) Qiao, H.; Zhang, S.; Li, K.; Cao, Z.; Zeng, F. J. Org.
Chem. 2019, 84, 10843. (f) Cendon, B.; Casanova, N.; Comanescu,
C.; García-Fandino, R.; Seoane, A.; Gulías, M.; Mascarenas, J. L. Org.
Lett. 2017, 19, 1674. (g) Archambeau, A.; Rovis, T. Angew. Chem., Int.
Ed. 2015, 54, 13337.
(8) (a) Font, M.; Cendon, B.; Seoane, A.; Mascaren
M. Angew. Chem., Int. Ed. 2018, 57, 8255. (b) Seoane, A.; Comanescu,
C.; Casanova, N.; García-Fandino, R.; Diz, X.; Mascarenas, J. L.;
Gulías, M. Angew. Chem., Int. Ed. 2019, 58, 1700.
(9) (a) Kerr, W. J.; Reid, M.; Tuttle, T. ACS Catal. 2015, 5, 402.
(b) Cheng, G.; Wang, P.; Yu, J.-Q. Angew. Chem., Int. Ed. 2017, 56,
8183.
Ming Sun − Guangzhou Municipal and Guangdong Provincial
Key Laboratory of Protein Modification and Degradation &
Molecular Target and Clinical Pharmacology, State Key
Laboratory of Respiratory Disease, School of Pharmaceutical
Sciences & the Fifth Affiliated Hospital, Guangzhou Medical
University, Guangzhou, Guangdong 511436, China
Complete contact information is available at:
Author Contributions
†L.L. and H.G. contributed equally.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
Financial support from NSFC (21877020) and Guangdong
Natural Science Funds for Distinguished Young Scholar
(2017A030306031) is gratefully acknowledged.
REFERENCES
■
(1) (a) Ammazzalorso, A.; De Filippis, B.; Giampietro, L.; Amoroso,
R. Chem. Biol. Drug Des. 2017, 90, 1094. (b) Shainyan, B. A.;
́
̃
̃
̈
Tolstikova, L. L. Chem. Rev. 2013, 113, 699. (c) Sielaff, F.; Bottcher-
̈
Friebertshauser, E.; Meyer, D.; Saupe, S. M.; Volk, I. M.; Garten, W.;
Steinmetzer, T. Bioorg. Med. Chem. Lett. 2011, 21, 4860. (d) Kokotos,
G.; Feuerherm, A. J.; Barbayianni, E.; Shah, I.; Sæther, M.; Magrioti,
V.; Nguyen, T.; Constantinou-Kokotou, V.; Dennis, E. A.; Johansen,
B. J. Med. Chem. 2014, 57, 7523. (e) Azevedo, C. M.; Watterson, K.
́
̃
as, J. L.; Gulías,
̃
̃
́
R.; Wargent, E. T.; Hansen, S. V.; Hudson, B. D.; Kep̧ czynska, M. A.;
Dunlop, J.; Shimpukade, B.; Christiansen, E.; Milligan, G.; Stocker, C.
J.; Ulven, T. J. Med. Chem. 2016, 59, 8868.
(2) For selected reviews, see: (a) Majumdar, K. C.; Mondal, S.
Chem. Rev. 2011, 111, 7749. (b) Rassadin, V. A.; Grosheva, D. S.;
Tomashevskii, A. A.; Sokolov, V. V. Chem. Heterocycl. Compd. 2013,
49, 39. (c) Debnath, S.; Mondal, S. Eur. J. Org. Chem. 2018, 8, 933.
(3) For selected examples of TM-catalyzed and sulfonamide-directed
aryl C−H activation, see: (a) Dai, H.-X.; Stepan, A. F.; Plummer, M.
S.; Zhang, Y.-H.; Yu, J.-Q. J. Am. Chem. Soc. 2011, 133, 7222.
(b) Pham, M. V.; Ye, B.; Cramer, N. Angew. Chem., Int. Ed. 2012, 51,
10610. (c) Ma, W.; Mei, R.; Tenti, G.; Ackermann, L. Chem. - Eur. J.
2014, 20, 15248. (d) Kalsi, D.; Sundararaju, B. Org. Lett. 2015, 17,
6118. (e) Planas, O.; Whiteoak, C. J.; Company, A.; Ribas, X. Adv.
Synth. Catal. 2015, 357, 4003. (f) Thrimurtulu, N.; Nallagonda, R.;
Volla, C. M. R. Chem. Commun. 2017, 53, 1872. (g) Nguyen, T. T.;
Grigorjeva, L.; Daugulis, O. Chem. Commun. 2017, 53, 5136. (h) Lan,
T.; Wang, L.; Rao, Y. Org. Lett. 2017, 19, 972. (i) Barsu, N.; Kalsi, D.;
(10) For representative examples of the combination of a Cp ligand
and an additive to affect the binding affinity and coordination
environment, see: (a) Piou, T.; Romanov-Michailidis, F.; Romanova-
Michaelides, M.; Jackson, K. E.; Semakul, N.; Taggart, T. D.; Newell,
B. S.; Rithner, C. D.; Paton, R. S.; Rovis, T. J. Am. Chem. Soc. 2017,
139, 1296. (b) Hong, S. Y.; Jeong, J.; Chang, S. Angew. Chem., Int. Ed.
2017, 56, 2408. (c) Piou, T.; Romanov-Michailidis, F.; Ashley, M. A.;
Romanova-Michaelides, M.; Rovis, T. J. Am. Chem. Soc. 2018, 140,
9587.
(11) (a) Drews, J. Science 2000, 287, 1960. (b) Scozzafava, A.; Owa,
T.; Mastrolorenzo, A.; Supuran, C. T. Curr. Med. Chem. 2003, 10,
925.
(12) For selected examples of intramolecular C−H functionalization
for the assembly of fused ring structures, see: (a) Li, G.; Liu, Q.;
E
Org. Lett. XXXX, XXX, XXX−XXX